Akinobu Yoshimura
Tokyo Medical University · 97 works · 1,860 citations · h-index 25
Top works
- The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias
- Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
- Three Dimensional Computed Tomography Lung Modeling is Useful in Simulation and Navigation of Lung Cancer Surgery
- Phase I study of E7010
- MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
- Somatic mutation of thehBUB1 mitotic checkpoint gene in primary lung cancer
- Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model
- A Pilot Study of Lung Cancer Screening with Low-Dose Spiral CT.
- Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis
- Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
- Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers
- Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation
- Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib
- Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database
- Can Interview Prior to Laparoscopic Simulator Training Predict a Trainee's Skills?
- The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias
- Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
- PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors
- Docetaxel in Combination with Either Cisplatin or Gemcitabine in Unresectable Non-small Cell Lung Carcinoma: A Randomized Phase II Study by the Japan Lung Cancer Cooperative Clinical Study Group
- Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer